JP5653401B2 - Method for producing powder-containing external preparation for skin containing emulsifier - Google Patents
Method for producing powder-containing external preparation for skin containing emulsifier Download PDFInfo
- Publication number
- JP5653401B2 JP5653401B2 JP2012228518A JP2012228518A JP5653401B2 JP 5653401 B2 JP5653401 B2 JP 5653401B2 JP 2012228518 A JP2012228518 A JP 2012228518A JP 2012228518 A JP2012228518 A JP 2012228518A JP 5653401 B2 JP5653401 B2 JP 5653401B2
- Authority
- JP
- Japan
- Prior art keywords
- external preparation
- skin
- powder
- mass
- slurry
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims description 51
- 239000000843 powder Substances 0.000 title claims description 40
- 238000004519 manufacturing process Methods 0.000 title claims description 19
- 239000003995 emulsifying agent Substances 0.000 title description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 62
- 239000002002 slurry Substances 0.000 claims description 29
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 18
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 14
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 9
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 9
- 239000012071 phase Substances 0.000 claims description 9
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 9
- 229940008099 dimethicone Drugs 0.000 claims description 7
- 239000004408 titanium dioxide Substances 0.000 claims description 7
- 239000011787 zinc oxide Substances 0.000 claims description 7
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 6
- 230000001804 emulsifying effect Effects 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 5
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 claims description 3
- 239000008346 aqueous phase Substances 0.000 claims description 2
- 229940086555 cyclomethicone Drugs 0.000 claims description 2
- 230000000699 topical effect Effects 0.000 claims description 2
- -1 ethanol Chemical compound 0.000 description 29
- 229920001296 polysiloxane Polymers 0.000 description 17
- 239000003921 oil Substances 0.000 description 16
- 239000002537 cosmetic Substances 0.000 description 15
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 13
- 235000014113 dietary fatty acids Nutrition 0.000 description 13
- 239000000194 fatty acid Substances 0.000 description 13
- 229930195729 fatty acid Natural products 0.000 description 13
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 239000011248 coating agent Substances 0.000 description 9
- 238000000576 coating method Methods 0.000 description 9
- 235000019198 oils Nutrition 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 8
- 239000006096 absorbing agent Substances 0.000 description 7
- 239000004359 castor oil Substances 0.000 description 7
- 235000019438 castor oil Nutrition 0.000 description 7
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 7
- 230000001681 protective effect Effects 0.000 description 7
- 239000004094 surface-active agent Substances 0.000 description 7
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 238000004945 emulsification Methods 0.000 description 5
- 239000010408 film Substances 0.000 description 5
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 5
- 230000002209 hydrophobic effect Effects 0.000 description 5
- 229910052751 metal Inorganic materials 0.000 description 5
- 239000002184 metal Substances 0.000 description 5
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 4
- 239000004166 Lanolin Substances 0.000 description 4
- 230000006750 UV protection Effects 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- 230000007794 irritation Effects 0.000 description 4
- 235000019388 lanolin Nutrition 0.000 description 4
- 229940039717 lanolin Drugs 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000000344 soap Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 229920001214 Polysorbate 60 Polymers 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 229960003237 betaine Drugs 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- 239000002734 clay mineral Substances 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000010445 mica Substances 0.000 description 2
- 229910052618 mica group Inorganic materials 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- 229960004063 propylene glycol Drugs 0.000 description 2
- MMXZSJMASHPLLR-UHFFFAOYSA-N pyrroloquinoline quinone Chemical compound C12=C(C(O)=O)C=C(C(O)=O)N=C2C(=O)C(=O)C2=C1NC(C(=O)O)=C2 MMXZSJMASHPLLR-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 238000006884 silylation reaction Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000003892 spreading Methods 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N β-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- 229940031723 1,2-octanediol Drugs 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- RKJGFHYCZPZJPE-UHFFFAOYSA-N 2,2-bis(16-methylheptadecanoyloxymethyl)butyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C RKJGFHYCZPZJPE-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- NCLNAHJFXIKYBY-UHFFFAOYSA-N 2-hexyldecyl 16-methylheptadecanoate Chemical compound CCCCCCCCC(CCCCCC)COC(=O)CCCCCCCCCCCCCCC(C)C NCLNAHJFXIKYBY-UHFFFAOYSA-N 0.000 description 1
- MUHFRORXWCGZGE-KTKRTIGZSA-N 2-hydroxyethyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCO MUHFRORXWCGZGE-KTKRTIGZSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- DJWYOLJPSHDSAL-UHFFFAOYSA-N Pantethine Natural products OCC(C)(C)C(O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)C(O)C(C)(C)CO DJWYOLJPSHDSAL-UHFFFAOYSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 239000006087 Silane Coupling Agent Substances 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 229920002359 Tetronic® Polymers 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- UDRYFKCHZFVZGJ-UHFFFAOYSA-N [5-hexadecanoyloxy-4-(hexadecanoyloxymethyl)-6-methylpyridin-3-yl]methyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC1=CN=C(C)C(OC(=O)CCCCCCCCCCCCCCC)=C1COC(=O)CCCCCCCCCCCCCCC UDRYFKCHZFVZGJ-UHFFFAOYSA-N 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 150000004347 all-trans-retinol derivatives Chemical class 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
- 229940063655 aluminum stearate Drugs 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 1
- 239000012964 benzotriazole Substances 0.000 description 1
- 229940066595 beta tocopherol Drugs 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- JJQZDUKDJDQPMQ-UHFFFAOYSA-N dimethoxy(dimethyl)silane Chemical compound CO[Si](C)(C)OC JJQZDUKDJDQPMQ-UHFFFAOYSA-N 0.000 description 1
- VJHINFRRDQUWOJ-UHFFFAOYSA-N dioctyl sebacate Chemical compound CCCCC(CC)COC(=O)CCCCCCCCC(=O)OCC(CC)CCCC VJHINFRRDQUWOJ-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229940113120 dipropylene glycol Drugs 0.000 description 1
- 239000002612 dispersion medium Substances 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- SYELZBGXAIXKHU-UHFFFAOYSA-N dodecyldimethylamine N-oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- OIKBVOIOVNEVJR-UHFFFAOYSA-N hexadecyl 6-methylheptanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCC(C)C OIKBVOIOVNEVJR-UHFFFAOYSA-N 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- TXGJTWACJNYNOJ-UHFFFAOYSA-N hexane-2,4-diol Chemical compound CCC(O)CC(C)O TXGJTWACJNYNOJ-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229960000448 lactic acid Drugs 0.000 description 1
- 229940071085 lauroyl glutamate Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- POPACFLNWGUDSR-UHFFFAOYSA-N methoxy(trimethyl)silane Chemical compound CO[Si](C)(C)C POPACFLNWGUDSR-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- GSGDTSDELPUTKU-UHFFFAOYSA-N nonoxybenzene Chemical compound CCCCCCCCCOC1=CC=CC=C1 GSGDTSDELPUTKU-UHFFFAOYSA-N 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- DJWYOLJPSHDSAL-ROUUACIJSA-N pantethine Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO DJWYOLJPSHDSAL-ROUUACIJSA-N 0.000 description 1
- 229960000903 pantethine Drugs 0.000 description 1
- 235000008975 pantethine Nutrition 0.000 description 1
- 239000011581 pantethine Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920001281 polyalkylene Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- ONQDVAFWWYYXHM-UHFFFAOYSA-M potassium lauryl sulfate Chemical compound [K+].CCCCCCCCCCCCOS([O-])(=O)=O ONQDVAFWWYYXHM-UHFFFAOYSA-M 0.000 description 1
- 229940116985 potassium lauryl sulfate Drugs 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 238000005245 sintering Methods 0.000 description 1
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940082004 sodium laurate Drugs 0.000 description 1
- 229940045870 sodium palmitate Drugs 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- GGXKEBACDBNFAF-UHFFFAOYSA-M sodium;hexadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCC([O-])=O GGXKEBACDBNFAF-UHFFFAOYSA-M 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229940071136 stearoyl glutamate Drugs 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 229940117986 sulfobetaine Drugs 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 150000003698 vitamin B derivatives Chemical class 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000011590 β-tocopherol Substances 0.000 description 1
- 235000007680 β-tocopherol Nutrition 0.000 description 1
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
Description
本発明は、皮膚外用剤に関し、詳しくは、化粧料などに有用な、乳化剤形の粉体含有皮膚外用剤に関する。 The present invention relates to an external preparation for skin, and more particularly to an emulsifier-type powder-containing external preparation for skin useful for cosmetics.
酸化亜鉛や二酸化チタンなどの粉体は、隠蔽性と紫外線防護効果を有することから、メークアップ化粧料や紫外線防護化粧料に広く使用されている。紫外線防護化粧料においては、ダメージを受けた肌に塗布される蓋然性が高いことから、塗布に際しての刺激付与を低減することが望まれ、直接粉体が皮膚を擦過しにくい乳化剤形が採用される場合が少なくない。 Powders such as zinc oxide and titanium dioxide are widely used in makeup cosmetics and ultraviolet protective cosmetics because they have a concealing property and an ultraviolet protective effect. In UV protection cosmetics, since it is highly likely to be applied to damaged skin, it is desired to reduce irritation at the time of application, and an emulsifier form in which the powder does not easily scratch the skin is adopted. There are many cases.
その一方、乳化系に於いては、比重1程度の粘性流動組成物で比重3以上の、酸化亜鉛や二酸化チタンなどの粉体を分散し、刹那に沈降しないようにその分散を維持する必要が存し、その為に、乳化系における粘性構造を利用している。この様な乳化系としては、脂肪酸石鹸を利用した水中油乳化系(例えば、特許文献1を参照)や、カチオン変性粘土鉱物、ポリアルキレンオキシド変性シリコーン或いは低重合度ポリグリセリンの低次エステルを利用した油中水乳化系(例えば、特許文献2、特許文献3を参照)が知られている。従って、この様な系に於いては、かかる粘性構造を破壊しやすいエタノールなどの低級アルコールの添加は殆ど不可能に近いと考えられていた。報告としては、分岐型のシリコーン系界面活性剤を使用することにより、エタノールを加えても、乳化安定性が向上するとの報告も存する(例えば、特許文献4を参照)が、かかる報告における乳化安定性は、振とう試験に対する安定性であり、この様な試験で安定と判別されても、実際使用での安定性とは乖離しており、実用に耐えるものとは言えないのが現状であった。 On the other hand, in an emulsifying system, it is necessary to disperse a powder such as zinc oxide or titanium dioxide having a specific gravity of 3 or more with a viscous fluid composition having a specific gravity of about 1, and to maintain the dispersion so that it does not settle in the moment. For this purpose, the viscous structure in the emulsification system is used. As such an emulsifying system, an oil-in-water emulsifying system using a fatty acid soap (see, for example, Patent Document 1), a cation-modified clay mineral, a polyalkylene oxide-modified silicone, or a low-order ester of polyglycerin having a low polymerization degree is used. A known water-in-oil emulsification system (see, for example, Patent Document 2 and Patent Document 3) is known. Therefore, in such a system, it was considered almost impossible to add a lower alcohol such as ethanol, which easily destroys the viscous structure. As a report, there is a report that the use of a branched silicone surfactant improves the emulsion stability even when ethanol is added (for example, see Patent Document 4). The stability is the stability with respect to the shaking test, and even if it is determined to be stable in such a test, it is deviated from the stability in actual use and it cannot be said that it can withstand practical use. It was.
粉体を含有する皮膚外用剤に於いて、粉体を予め液性成分とともにスラリーに予備的に加工し、しかる後に乳化製剤に製剤化する方法は既に知られている(例えば、特許文献5、特許文献6を参照)が、この様な系にエタノールなどの低級アルコールを含有させる試みは全く為されていないし、この様な製造方法に於いて、安定性を損なうことなく低級アルコールの添加が可能になることは予想だにし得ないことであった。 In skin external preparations containing powder, a method is known in which powder is preliminarily processed into a slurry together with liquid components and then formulated into an emulsified preparation (for example, Patent Document 5, However, no attempt has been made to contain such a lower alcohol such as ethanol in such a system, and in such a production method, it is possible to add a lower alcohol without impairing stability. It was impossible to expect.
粉体含有乳化系への低級アルコールの添加は、低級アルコールが揮散成分であるが故に、化粧持ちに影響を与えず、のびが改善するなど、その使用性を向上させ、且つ、防腐の見地からも、防腐力を高めるので、望まれていることではあったが、前記の事情により達成されていないのが現状であった。 Addition of lower alcohol to the powder-containing emulsification system, because lower alcohol is a volatilizing component, it has no effect on cosmetics, improves spreading and improves usability, and from the standpoint of preserving However, since it increases the antiseptic power, it has been desired, but it has not been achieved due to the above circumstances.
本発明は、この様な状況下為されたものであり、粉体を含有する乳化剤形の皮膚外用剤
に於いて、エタノールなどの低級アルコールを、安定性を損なうことなく、含有させる技術を開発し、以て、粉体含有乳化剤形の皮膚外用剤の使用性を向上させることを課題とする。
The present invention has been made under such circumstances, and in a skin emulsifier type external preparation containing powder, developed a technique for containing a lower alcohol such as ethanol without impairing stability. Therefore, it is an object to improve the usability of the powder-containing emulsifier type skin external preparation.
この様な状況に鑑みて、本発明者らは、粉体を含有する乳化剤形の皮膚外用剤に於いて、エタノールなどの低級アルコールを、安定性を損なうことなく、含有させる技術を求めて、鋭意研究努力を重ねた結果、グリセリン変性メチルポリシロキサン(ポリグリセリル−3−ポリジメチルシロキシエチルジメチコン)を界面活性剤として用いることにより、この様な配合が為しうることを見いだし、発明を完成させるに至った。即ち、本発明は、以下に示すとおりである。
<1>1)粉体、2)低級アルコール、及び3)グリセリン変性メチルポリシロキサンを含有する乳化剤形の皮膚外用剤の製造方法であって、
前記1)粉体と、3)グリセリン変性メチルポリシロキサンとを、油性担体に分散させ、スラリーとする工程、
前記スラリーと他の油相成分を混合して油相とする工程、及び
前記油相と2)低級アルコール3〜20質量%を含有する水相を混合して乳化させる工程、を含む皮膚外用剤の製造方法。
In view of such a situation, the present inventors have sought for a technique for containing a lower alcohol such as ethanol without impairing stability in an emulsifier-type skin external preparation containing powder. As a result of intensive research efforts, it has been found that such a blending can be achieved by using glycerin-modified methylpolysiloxane (polyglyceryl-3-polydimethylsiloxyethyl dimethicone) as a surfactant, thereby completing the invention. It came. That is, the present invention is as follows.
<1> A method for producing an emulsifier-type skin external preparation containing 1) powder, 2) lower alcohol, and 3) glycerin-modified methylpolysiloxane,
A step of dispersing the 1) powder and 3) glycerin-modified methylpolysiloxane in an oily carrier to form a slurry ;
Step of the previous SL slurry and a mixture of other oil phase components an oil phase and,
A method for producing an external preparation for skin, comprising the step of mixing and emulsifying the oil phase and 2) an aqueous phase containing 3 to 20% by mass of a lower alcohol.
本発明によれば、粉体を含有する乳化剤形の皮膚外用剤に於いて、エタノールなどの低級アルコールを、安定性を損なうことなく、含有させる技術を提供し、以て、粉体含有乳化剤形の皮膚外用剤の使用性を向上させることができる。 According to the present invention, there is provided a technique for containing a lower alcohol such as ethanol without impairing stability in an emulsifier-type skin external preparation containing powder, and thus a powder-containing emulsifier form. Usability of the external preparation for skin can be improved.
<1>本発明の皮膚外用剤の必須成分である粉体
本発明の皮膚外用剤は乳化剤形であって、粉体を含有することを特徴とする。前記粉体としては、例えば、酸化鉄、シリカ、アルミナ、ジルコニアなどの他の金属で、焼結、表面被覆などの複合化されていても良い二酸化チタン、酸化亜鉛、或いは、酸化鉄、タルク、マイカ、セリサイト、カオリン、マイカチタニア、セリサイトチタニア等の体質粉体などが好適に例示できる。これらの内では、紫外線防護効果の著しい酸化亜鉛乃至は二酸化チタンが特に好ましい。前記粉体は、表面を処理された形で含有されることが好ましく、乳化剤形が油中水乳化剤形であれば、前記表面処理は疎水化処理であることが好ましい。前記疎水化処理としては、例えば、ステアリン酸アルミニウム、ステアリン酸亜鉛等の金属石鹸による被覆処理、N−ステアロイルグルタミン酸アルミニウム、N−ラウロイルグルタミン酸アルミニウム等のN−アシルアミノ酸金属塩による被覆処理、レシチンなどのリン脂質による被覆処理、ハイドロジェンメチルポリシロキサンやジメチルポリシロキサン等のシリコーン焼付処理、ジメトキシジメチルシラン、メトキシトリメチルシランなどのシランカップリング剤処理によるシリル化処理などが存する。かかる処理は粉体100質量部に対して、1〜30質量部、より好ましくは10〜25質量部の処理剤を用いて行うことが好ましい。乳化剤形が油中水乳化剤形である場合、本発明では、かかる粉体表面には疎水化処理を予め行って使用することが好ましい。
<1> Powder which is an essential component of the external preparation for skin of the present invention The external preparation for skin of the present invention is in an emulsifier form and contains powder. Examples of the powder include, for example, other metals such as iron oxide, silica, alumina, and zirconia, and titanium dioxide, zinc oxide, or iron oxide, talc, which may be combined by sintering, surface coating, etc. Preferred examples include body powders such as mica, sericite, kaolin, mica titania, and sericite titania. Among these, zinc oxide or titanium dioxide having a remarkable ultraviolet protection effect is particularly preferable. The powder is preferably contained in a surface-treated form, and if the emulsifier form is a water-in-oil emulsifier form, the surface treatment is preferably a hydrophobic treatment. Examples of the hydrophobizing treatment include coating treatment with a metal soap such as aluminum stearate and zinc stearate, coating treatment with an N-acylamino acid metal salt such as aluminum N-stearoyl glutamate and aluminum N-lauroyl glutamate, and lecithin. There are coating treatment with phospholipid, silicone baking treatment such as hydrogenmethylpolysiloxane and dimethylpolysiloxane, and silylation treatment by silane coupling agent treatment such as dimethoxydimethylsilane and methoxytrimethylsilane. Such treatment is preferably performed using 1 to 30 parts by mass, more preferably 10 to 25 parts by mass of the treatment agent with respect to 100 parts by mass of the powder. When the emulsifier form is a water-in-oil emulsifier form, in the present invention, it is preferable that the powder surface is subjected to a hydrophobic treatment in advance.
処理の仕方は、金属塩の被覆処理であれば、粉体存在下、水などを担体として、当該金属の水可溶性塩と、疎水基相当部分の可溶性塩とを水性溶液状態で混合し、塩基交換反応を行い、疎水性塩を粉体表面上に沈降させて、これを取り出し、乾燥させて疎水性被覆膜を形成させればよい。 In the case of a metal salt coating treatment, in the presence of powder, water or the like is used as a carrier, and the water-soluble salt of the metal and the soluble salt corresponding to the hydrophobic group are mixed in an aqueous solution state to form a base. An exchange reaction may be performed to precipitate the hydrophobic salt on the powder surface, which may be taken out and dried to form a hydrophobic coating film.
処理の仕方に於いて、シリコーン類の焼付処理やシリル化処理においては、処理剤を、例えば、塩化メチレンなどの非反応性揮発溶剤に溶解せしめ、粉体の表面に均一に被覆させ、溶剤を揮散させて処理剤の薄膜を形成せしめ、これに200〜400℃の熱処理を数
時間から一昼夜行うことにより、疎水性被覆膜を形成させればよい。
In the treatment method, in the baking treatment and silylation treatment of silicones, the treatment agent is dissolved in, for example, a non-reactive volatile solvent such as methylene chloride and uniformly coated on the surface of the powder. A hydrophobic coating film may be formed by volatilizing to form a thin film of the treating agent and performing a heat treatment at 200 to 400 ° C. for several hours to one day.
<製造例1>
微粒子二酸化チタン32質量部をフローコーターに仕込み、これに塩化メチレン100質量部にハイドロジェンメチルポリシロキサン6質量部とジメチコン2質量部とを溶かした液を噴霧しながら送風してコーティングを行った。コーティング終了後更に4時間40℃の温風を送風し、溶剤を揮散させた。この粉体を電気炉に仕込み210℃で一昼夜加熱して焼付を行い、疎水化処理粉体を得た。この疎水化処理粉体を0.9mm丸穴スクリーンを装着したパルベライザーで粉砕し、処理粉体1を得た。
<Production Example 1>
32 parts by mass of fine particle titanium dioxide was charged into a flow coater, and coating was performed by blowing air while spraying a solution obtained by dissolving 6 parts by mass of hydrogenmethylpolysiloxane and 2 parts by mass of dimethicone in 100 parts by mass of methylene chloride. After the coating was completed, hot air at 40 ° C. was further blown for 4 hours to volatilize the solvent. This powder was charged into an electric furnace and baked by heating at 210 ° C. for a whole day and night to obtain a hydrophobized powder. This hydrophobized powder was pulverized with a pulverizer equipped with a 0.9 mm round hole screen to obtain treated powder 1.
<製造例2>
製造例1と同様に、87質量部の酸化亜鉛を、100質量部の塩化メチレンに、10質量部のジメチコンと3質量部のハイドロジェンメチルポリシロキサンとを溶かした溶液で処理し、処理粉体2を得た。
<Production Example 2>
In the same manner as in Production Example 1, 87 parts by mass of zinc oxide was treated with a solution of 10 parts by mass of dimethicone and 3 parts by mass of hydrogenmethylpolysiloxane in 100 parts by mass of methylene chloride. 2 was obtained.
<2>本発明の皮膚外用剤の必須成分である低級アルコール
本発明の皮膚外用剤は、低級アルコールを必須成分として含有することを特徴とする。前記低級アルコールとしては、例えば、エタノールやイソプロパノールが好適に例示できる。特にエタノールを採用することが好ましい。かかる低級アルコールの好ましい含有量は、3〜20質量%が好ましく、より好ましくは、5〜15質量%であり、更に好ましくは6〜10質量%である。本発明の皮膚外用剤における低級アルコールの効果は、塗布時の皮膚との摩擦係数を低下させる等により使用感を向上させること、塗布後に化粧膜より揮散し、化粧膜の親水性の成分の含有量を低下せしめ、これによって、塗布後に形成される化粧膜の強度を向上させること、及び、製品における防腐力を向上せしめることである。前記の配合量を下回る場合には、前記の効果の何れか或いは全てが発揮されない場合が存し、多すぎると、乳化或いは粉体分散の安定性を損なう場合が存する。
<2> Lower alcohol which is an essential component of the external preparation for skin of the present invention The external preparation for skin of the present invention is characterized by containing a lower alcohol as an essential component. Suitable examples of the lower alcohol include ethanol and isopropanol. It is particularly preferable to employ ethanol. The content of the lower alcohol is preferably 3 to 20% by mass, more preferably 5 to 15% by mass, and still more preferably 6 to 10% by mass. The effect of the lower alcohol in the external preparation for skin of the present invention is to improve the feeling of use, for example, by reducing the friction coefficient with the skin at the time of application, volatilizes from the cosmetic film after application, and contains the hydrophilic component of the cosmetic film It is to reduce the amount, thereby improving the strength of the decorative film formed after application, and improving the antiseptic power in the product. When the amount is less than the above-mentioned blending amount, any or all of the above effects may not be exhibited, and when too large, the stability of emulsification or powder dispersion may be impaired.
<3>本発明の皮膚外用剤の必須成分であるグリセリン変性メチルポリシロキサン(ポリグリセリル−3−ポリジメチルシロキシエチルジメチコン)
本発明の皮膚外用剤は、乳化剤形であって、グリセリン変性メチルポリシロキサン(ポリグリセリル−3−ポリジメチルシロキシエチルジメチコン)を必須成分として含有する。本発明の皮膚外用剤は、前述の如くに、乳化によって形成される構造を破壊しやすいエタノールを必須成分として含有するが、界面活性剤としてグリセリン変性メチルポリシロキサンを採用することにより、この様なアルコールによる影響を軽減することを特徴とする。この様なグリセリン変性シリコーンは化粧料原料として市販されているものを使用することが出来、かかる市販品としては、例えば、信越化学株式会社製の「シリコーンKF6104」等が好適に例示できる。かかるグリセリン変性メチルポリシロキサンは唯一種を含有することも出来るし、二種以上を組み合わせて含有させることも出来る。かかる成分の好ましい含有量は、総量で、皮膚外用剤全量に対して、0.5〜4質量%であり、より好ましくは0.8〜1.5質量%である。かかる成分は、疎水化処理粉体の分散性向上に優れた作用を有するため、予め、疎水化処理粉体をかかる成分とともにジメチコンやシクロメチコンなどの油性担体に分散させ、スラリーの形に加工して、皮膚外用剤の製造に用いることが好ましい。スラリーの作成に際しては、グリセリン変性メチルポリシロキサン1質量部に対し、粉体10〜20質量部、油性担体10〜20質量部を加え、ボールミル、コボルミル、ダイノミルなどの媒体ミルを用いてスラリーに加工することが好適に例示できる。かかるグリセリン変性メチルポリシロキサンは、スラリーとは別に油相に乳化の界面活性剤として添加することも出来る。
<3> Glycerin-modified methylpolysiloxane (polyglyceryl-3-polydimethylsiloxyethyl dimethicone) which is an essential component of the external preparation for skin of the present invention
The external preparation for skin of the present invention is in an emulsifier form and contains glycerin-modified methylpolysiloxane (polyglyceryl-3-polydimethylsiloxyethyl dimethicone) as an essential component. As described above, the external preparation for skin of the present invention contains, as an essential component, ethanol that easily destroys the structure formed by emulsification. By adopting glycerin-modified methylpolysiloxane as a surfactant, such an external preparation is used. It is characterized by reducing the influence of alcohol. As such a glycerin-modified silicone, those commercially available as cosmetic raw materials can be used, and examples of such commercially available products include “silicone KF6104” manufactured by Shin-Etsu Chemical Co., Ltd., and the like. Such glycerin-modified methylpolysiloxane may contain only one species or may contain two or more species in combination. The preferable content of such components is 0.5 to 4% by mass, more preferably 0.8 to 1.5% by mass, based on the total amount of the external preparation for skin, as a total amount. Since this component has an excellent action for improving the dispersibility of the hydrophobized powder, the hydrophobized powder is previously dispersed in an oily carrier such as dimethicone or cyclomethicone together with the component and processed into a slurry form. Therefore, it is preferably used for the manufacture of a skin external preparation. In preparing the slurry, 10 to 20 parts by weight of powder and 10 to 20 parts by weight of an oily carrier are added to 1 part by weight of glycerin-modified methylpolysiloxane, and processed into a slurry using a media mill such as a ball mill, a covol mill, or a dyno mill. It can be preferably exemplified. Such glycerin-modified methylpolysiloxane can be added as an emulsifying surfactant to the oil phase separately from the slurry.
<4>本発明の皮膚外用剤
本発明の皮膚外用剤は、前記必須成分を含有し、乳化剤形であることを特徴とする。前
記乳化剤形としては、脂肪酸石鹸の界面活性剤乳化構造を利用した水中油乳化剤形、或いは、有機変性粘土鉱物、ポリグリセリン脂肪酸エステル、シリコーン系界面活性剤を利用した油中水乳化剤形が好適に例示できる。特に油中水乳化剤形が、エタノールの影響を粉体分散性に及ぼしにくいので好ましい。油中水乳化剤形にあっては、前記のグリセリン変性メチルポリシロキサンに加えて、ポリオキシエチレン・ポリオキシプロピレン変性メチルポリシロキサンを含有することが好ましく、かかるシリコーン系界面活性剤は、乳化の安定性を向上せしめる。この様な効果を奏するためには、当該成分は、皮膚外用剤全量に対して、0.1〜4質量%含有することが好ましく、0.2〜1質量%含有することが特に好ましい。ここで、油中水乳化剤形とは、最外相に油相を配する乳化剤形の総称で、油中水中油剤形などの複合剤形も包含する概念である。
<4> External preparation for skin of the present invention The external preparation for skin of the present invention contains the essential components and is in the form of an emulsifier. As the emulsifier form, an oil-in-water emulsifier form utilizing a surfactant emulsified structure of fatty acid soap, or a water-in-oil emulsifier form utilizing an organically modified clay mineral, polyglycerin fatty acid ester, or silicone surfactant is suitable. It can be illustrated. In particular, the water-in-oil emulsifier form is preferred because it hardly affects the dispersibility of ethanol. In the case of the water-in-oil emulsifier type, it is preferable to contain polyoxyethylene / polyoxypropylene-modified methylpolysiloxane in addition to the glycerin-modified methylpolysiloxane. Improve sex. In order to exert such effects, the component is preferably contained in an amount of 0.1 to 4% by mass, particularly preferably 0.2 to 1% by mass, based on the total amount of the external preparation for skin. Here, the water-in-oil emulsifier form is a general term for the emulsifier form in which the oil phase is arranged in the outermost phase, and is a concept including a composite dosage form such as an oil-in-water oil form.
本発明の皮膚外用剤は、乳化剤形であって、エタノールなどの低級アルコールを含有し、のびの良さ、化粧持ちの良さなどの特徴を有する。この為、ダメージを受けた肌に塗布しても、粉体が直接皮膚を擦過することによって生じる、物理的な刺激も低い。加えて、酸化亜鉛や二酸化チタンを粉体として用いると、紫外線遮蔽効果が著しく、紫外線防護用の化粧料としての優れた機能を有する。この為、紫外線防護化粧料に適用することが好ましい。 The external preparation for skin of the present invention is in the form of an emulsifier, contains a lower alcohol such as ethanol, and has characteristics such as good stretchability and good longevity. For this reason, even when applied to damaged skin, the physical irritation caused by the powder directly rubbing the skin is low. In addition, when zinc oxide or titanium dioxide is used as a powder, the ultraviolet ray shielding effect is remarkable, and it has an excellent function as a cosmetic for UV protection. For this reason, it is preferable to apply to UV protection cosmetics.
本発明の皮膚外用剤においては、かかる成分以外に、通常皮膚外用剤で使用される任意成分を含有することが出来る。この様な任意成分としては、例えば、マカデミアナッツ油、アボカド油、トウモロコシ油、オリーブ油、ナタネ油、ゴマ油、ヒマシ油、サフラワー油、綿実油、ホホバ油、ヤシ油、パーム油、液状ラノリン、硬化ヤシ油、硬化油、モクロウ、硬化ヒマシ油、ミツロウ、キャンデリラロウ、カルナウバロウ、イボタロウ、ラノリン、還元ラノリン、硬質ラノリン、ホホバロウ等のオイル、ワックス類;流動パラフィン、スクワラン、プリスタン、オゾケライト、パラフィン、セレシン、ワセリン、マイクロクリスタリンワックス等の炭化水素類;オレイン酸、イソステアリン酸、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ベヘン酸、ウンデシレン酸等の高級脂肪酸類;セチルアルコール、ステアリルアルコール、イソステアリルアルコール、ベヘニルアルコール、オクチルドデカノール、ミリスチルアルコール、セトステアリルアルコール等の高級アルコール等;イソオクタン酸セチル、ミリスチン酸イソプロピル、イソステアリン酸ヘキシルデシル、アジピン酸ジイソプロピル、セバチン酸ジ−2−エチルヘキシル、乳酸セチル、リンゴ酸ジイソステアリル、ジ−2−エチルヘキサン酸エチレングリコール、ジカプリン酸ネオペンチルグリコール、ジ−2−ヘプチルウンデカン酸グリセリン、トリ−2−エチルヘキサン酸グリセリン、トリ−2−エチルヘキサン酸トリメチロールプロパン、トリイソステアリン酸トリメチロールプロパン、テトラ−2−エチルヘキサン酸ペンタンエリトリット等の合成エステル油類;ジメチルポリシロキサン、メチルフェニルポリシロキサン、ジフェニルポリシロキサン等の鎖状ポリシロキサン;オクタメチルシクロテトラシロキサン、デカメチルシクロペンタシロキサン、ドデカメチルシクロヘキサンシロキサン等の環状ポリシロキサン;アミノ変性ポリシロキサン、アルキル変性ポリシロキサン、フッ素変性ポリシロキサン等の変性ポリシロキサン等のシリコーン油等の油剤類;脂肪酸セッケン(ラウリン酸ナトリウム、パルミチン酸ナトリウム等)、ラウリル硫酸カリウム、アルキル硫酸トリエタノールアミンエーテル等のアニオン界面活性剤類;塩化ステアリルトリメチルアンモニウム、塩化ベンザルコニウム、ラウリルアミンオキサイド等のカチオン界面活性剤類;イミダゾリン系両性界面活性剤(2−ココイル−2−イミダゾリニウムヒドロキサイド−1−カルボキシエチロキシ2ナトリウム塩等)、ベタイン系界面活性剤(アルキルベタイン、アミドベタイン、スルホベタイン等)、アシルメチルタウリン等の両性界面活性剤類;ソルビタン脂肪酸エステル類(ソルビタンモノステアレート、セスキオレイン酸ソルビタン等)、グリセリン脂肪酸類(モノステアリン酸グリセリン等)、プロピレングリコール脂肪酸エステル類(モノステアリン酸プロピレングリコール等)、硬化ヒマシ油誘導体、グリセリンアルキルエーテル、POEソルビタン脂肪酸エステ
ル類(POEソルビタンモノオレエート、モノステアリン酸ポリオキエチレンソルビタン等)、POEソルビット脂肪酸エステル類(POE−ソルビットモノラウレート等)、POEグリセリン脂肪酸エステル類(POE−グリセリンモノイソステアレート等)、POE脂肪酸エステル類(ポリエチレングリコールモノオレート、POEジステアレート等)、POEアルキルエーテル類(POE2−オクチルドデシルエーテル等)、POEアルキルフェニルエーテル類(POEノニルフェニルエーテル等)、プルロニック型類、POE・POPアルキルエーテル類(POE・POP2−デシルテトラデシルエーテル等)、テトロニック類、POEヒマシ油・硬化ヒマシ油誘導体(POEヒマシ油、POE硬化ヒマシ油等)、ショ糖脂肪酸エステル、アルキルグルコシド等の非イオン界面活性剤類;ポリエチレングリコール、グリセリン、1,3−ブチレングリコール、エリスリトール、ソルビトール、キシリトール、マルチトール、プロピレングリコール、ジプロピレングリコール、ジグリセリン、イソプレングリコール、1,2−ペンタンジオール、2,4−ヘキサンジオール、1,2−ヘキサンジオール、1,2−オクタンジオール等の多価アルコール類;ピロリドンカルボン酸ナトリウム、乳酸、乳酸ナトリウム等の保湿成分類;パラアミノ安息香酸系紫外線吸収剤;アントラニル酸系紫外線吸収剤;サリチル酸系紫外線吸収剤;桂皮酸系紫外線吸収剤;ベンゾフェノン系紫外線吸収剤;糖系紫外線吸収剤;2−(2’−ヒドロキシ−5’−t−オクチルフェニル)ベンゾトリアゾール、4−メトキシ−4’−t−ブチルジベンゾイルメタン等の紫外線吸収剤類;エタノール、イソプロパノール等の低級アルコール類;ビタミンA又はその誘導体、ビタミンB6塩酸塩、ビタミンB6トリパルミテート、ビタミンB6ジオクタノエート、ビタミンB2又はその誘導体、ビタミンB12、ビタミンB15又はその誘導体等のビタミンB類;α−トコフェロール、β−トコフェロール、γ−トコフェロール、ビタミンEアセテート等のビタミンE類、ビタミンD類、ビタミンH、パントテン酸、パンテチン、ピロロキノリンキノン等のビタミン類等;フェノキシエタノール等の抗菌剤などが好ましく例示できる。
The external preparation for skin of the present invention can contain, in addition to such components, optional components that are usually used in external preparations for skin. Examples of such optional ingredients include macadamia nut oil, avocado oil, corn oil, olive oil, rapeseed oil, sesame oil, castor oil, safflower oil, cottonseed oil, jojoba oil, coconut oil, palm oil, liquid lanolin, and hardened coconut oil. Oil, wax, oils such as beeswax, owl, hydrogenated castor oil, beeswax, candelilla wax, carnauba wax, ibotarou, lanolin, reduced lanolin, hard lanolin, jojoba wax; liquid paraffin, squalane, pristane, ozokerite, paraffin, ceresin, petrolatum , Hydrocarbons such as microcrystalline wax; higher fatty acids such as oleic acid, isostearic acid, lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, undecylenic acid; cetyl alcohol, stearyl alcohol, isostearyl Higher alcohols such as alcohol, behenyl alcohol, octyldodecanol, myristyl alcohol, cetostearyl alcohol; cetyl isooctanoate, isopropyl myristate, hexyldecyl isostearate, diisopropyl adipate, di-2-ethylhexyl sebacate, cetyl lactate, malic acid Diisostearyl, di-2-ethylhexanoic acid ethylene glycol, dicaprate neopentyl glycol, di-2-heptylundecanoic acid glycerin, tri-2-ethylhexanoic acid glycerin, tri-2-ethylhexanoic acid trimethylolpropane, tri Synthetic ester oils such as trimethylolpropane isostearate and pentane erythritol tetra-2-ethylhexanoate; dimethylpolysiloxane, methylphenylpoly Chain polysiloxanes such as Loxane and diphenylpolysiloxane; Cyclic polysiloxanes such as octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, and dodecamethylcyclohexanesiloxane; amino-modified polysiloxanes, alkyl-modified polysiloxanes, fluorine-modified polysiloxanes, etc. Oils such as silicone oils such as modified polysiloxanes; Anionic surfactants such as fatty acid soap (sodium laurate, sodium palmitate, etc.), potassium lauryl sulfate, trisulfamine amine alkyl sulfate; stearyltrimethylammonium chloride, benzaza chloride Cationic surfactants such as luconium and laurylamine oxide; imidazoline-based amphoteric surfactants (2-cocoyl-2-imidazolinium hydroxide-1-carb Ruboxyethyloxy disodium salt), betaine surfactants (alkyl betaine, amide betaine, sulfobetaine, etc.), amphoteric surfactants such as acylmethyl taurine; sorbitan fatty acid esters (sorbitan monostearate, sesquiolein) Sorbitan acid, etc.), glycerin fatty acids (glyceryl monostearate, etc.), propylene glycol fatty acid esters (propylene glycol monostearate, etc.), hardened castor oil derivatives, glycerin alkyl ethers, POE sorbitan fatty acid esters (POE sorbitan monooleate) , Monostearic acid polyoxyethylene sorbitan, etc.), POE sorbite fatty acid esters (POE-sorbite monolaurate, etc.), POE glycerin fatty acid esters (POE-glycerin mono) Sotearate, etc.), POE fatty acid esters (polyethylene glycol monooleate, POE distearate, etc.), POE alkyl ethers (POE2-octyldodecyl ether, etc.), POE alkyl phenyl ethers (POE nonyl phenyl ether, etc.), Pluronic types, POE -POP alkyl ethers (POE / POP2-decyltetradecyl ether, etc.), Tetronics, POE castor oil / hardened castor oil derivatives (POE castor oil, POE hardened castor oil, etc.), sucrose fatty acid esters, alkyl glucosides, etc. Nonionic surfactants: polyethylene glycol, glycerin, 1,3-butylene glycol, erythritol, sorbitol, xylitol, maltitol, propylene glycol, dipropylene glycol , Diglycerin, isoprene glycol, 1,2-pentanediol, 2,4-hexanediol, 1,2-hexanediol, 1,2-octanediol and other polyhydric alcohols; sodium pyrrolidonecarboxylate, lactic acid, sodium lactate Moisturizing ingredients such as paraaminobenzoic acid UV absorbers; anthranilic acid UV absorbers; salicylic acid UV absorbers; cinnamic acid UV absorbers; benzophenone UV absorbers; sugar UV absorbers; UV absorbers such as'-hydroxy-5'-t-octylphenyl) benzotriazole and 4-methoxy-4'-t-butyldibenzoylmethane; lower alcohols such as ethanol and isopropanol; vitamin A or a derivative thereof; vitamin B 6 hydrochloride, vitamin B 6 tripalmitate, vitamin B 6 Octanoate, vitamin B 2 or derivatives thereof, vitamin B 12, vitamin B such as vitamin B 15 or a derivative thereof; alpha-tocopherol, beta-tocopherol, .gamma.-tocopherol, vitamin E such as vitamin E acetate, vitamin D, Preferable examples include vitamins such as vitamin H, pantothenic acid, pantethine and pyrroloquinoline quinone; and antibacterial agents such as phenoxyethanol.
前記の必須成分、好ましい成分、任意成分を常法に従って処理することにより、本発明の皮膚外用剤は製造できる。
以下に、実施例を挙げて、本発明について、更に詳細に説明を加える。
The skin external preparation of this invention can be manufactured by processing the said essential component, a preferable component, and an arbitrary component in accordance with a conventional method.
Hereinafter, the present invention will be described in more detail with reference to examples.
<実施例1>
<スラリーの製造1>
下記に示す処方に従って、スラリー1を製造した。即ち、処方成分をコボルミルに仕込み、0.1質量倍のジルコニアのボールを加えて、高速回転で1時間分散させ、濾過により分散媒体のジルコニアボールを取り除き、スラリー1を得た。同様に操作して、「シリコーンKF6104」を「シリコーンKF6017」(POE変性メチルポリシロキサン;信越化学株式会社製)に置換した比較スラリー1も作成した。
<Example 1>
<Manufacture of slurry 1>
Slurry 1 was produced according to the formulation shown below. That is, the prescription ingredients were charged into a Covol mill, 0.1 mass times zirconia balls were added and dispersed at high speed for 1 hour, and the dispersion medium zirconia balls were removed by filtration to obtain slurry 1. In the same manner, Comparative Slurry 1 in which “silicone KF6104” was replaced with “silicone KF6017” (POE-modified methylpolysiloxane; manufactured by Shin-Etsu Chemical Co., Ltd.) was also prepared.
スラリー1と比較スラリー1とを比較した。比較は、皮膚に延展時の白さの加減と、20℃で平衡状態に達したときの粘度で行った。白さの加減は、スラリーを20μlとり、
これを前腕内側部の2cm×4cmの部位に手指で延展し、広がったところでの見た目の白さを、スコア0:白く感じない、スコア1:白いが自然な白さ、スコア2:やや不自然さが伺える白さ、スコア3:少し不自然な白さ、スコア4:不自然な白さの基準でスコアを賦して行った。結果を表2に示す。本発明の皮膚外用剤に好適なスラリーは粘度が低く、白が突出していないことが分かる。
Slurry 1 and comparative slurry 1 were compared. The comparison was made by adjusting the whiteness at the time of spreading on the skin and the viscosity when reaching an equilibrium state at 20 ° C. To adjust the whiteness, take 20 μl of slurry,
This is extended to the 2 cm x 4 cm part of the inner forearm with fingers, and the whiteness of the appearance when spread is score 0: white is not felt, score 1: white is natural white, score 2: somewhat unnatural The score was assigned on the basis of whiteness, score 3: slightly unnatural whiteness, and score 4: unnatural whiteness. The results are shown in Table 2. It turns out that the slurry suitable for the skin external preparation of this invention has a low viscosity, and white does not protrude.
<スラリーの製造2>
スラリーの製造1と同様に、下記の処方に従ってスラリー2及び、「シリコーンKF6104」を「シリコーンKF6017」(POE変性メチルポリシロキサン;信越化学株式会社製)に置換した比較スラリー2を作成した。前記の手技に従って、評価も行った。結果を表4に示すが、同様の結果であった。
<Manufacture of slurry 2>
In the same manner as in the production of slurry 1, according to the following formulation, slurry 2 and comparative slurry 2 in which “silicone KF6104” was replaced with “silicone KF6017” (POE-modified methylpolysiloxane; manufactured by Shin-Etsu Chemical Co., Ltd.) were prepared. Evaluation was also performed according to the procedure described above. The results are shown in Table 4 and were similar results.
前記のスラリーを使用して、本発明の皮膚外用剤を作成した。即ち、イ、ロの成分をそれぞれ80℃に加熱し、攪拌下イに徐々にロを加え乳化し、これを攪拌冷却し、本発明の皮膚外用剤1(紫外線防護化粧料)を得た。同様に、スラリー1を比較スラリー1に、且つ、スラリー2を比較スラリー2に置換した比較例1も作成した。 The skin external preparation of this invention was created using the said slurry. That is, components (a) and (b) were each heated to 80 ° C., and gradually added to emulsify with stirring, followed by stirring and cooling to obtain a skin external preparation 1 (ultraviolet protective cosmetic) of the present invention. Similarly, Comparative Example 1 in which slurry 1 was replaced with comparative slurry 1 and slurry 2 was replaced with comparative slurry 2 was also prepared.
<実施例2>
同様に操作して、本発明の皮膚外用剤である、皮膚外用剤2(紫外線防護化粧料)を作成した。
<Example 2>
In the same manner, skin external preparation 2 (ultraviolet protective cosmetic), which is the skin external preparation of the present invention, was prepared.
<実施例3>
同様に操作して、本発明の皮膚外用剤である、皮膚外用剤3(紫外線防護化粧料)を作成した。
<Example 3>
In the same manner, skin external preparation 3 (ultraviolet protective cosmetic), which is the skin external preparation of the present invention, was prepared.
<参考例4>
同様に操作して、皮膚外用剤4(紫外線防護化粧料)を作成した。
<Reference Example 4>
In the same manner, a skin external preparation 4 (ultraviolet protective cosmetic) was prepared.
<評価例1>
皮膚外用剤1〜4及び比較例1について、その性状を評価した。評価はスラリーと同様に粘度と、白ぽっさを評価した。又、40℃で1ヶ月、3ヶ月保存したときの性状の変化も観察した。保存安定性は外観の観察で分離や粉体の沈降の有無を観察した。結果を表9に示す。本発明の皮膚外用剤は使用実感に優れており、安定性も高いことが分かった。又、スラリー中にグリセリン変性メチルポリシロキサンを含有せしめることが好ましいことも分かった。
<Evaluation Example 1>
About the skin external preparations 1-4 and the comparative example 1, the property was evaluated. Evaluation evaluated the viscosity and whiteness like the slurry. In addition, changes in properties when stored at 40 ° C. for 1 month or 3 months were also observed. Storage stability was determined by observing the appearance of separation and powder settling. The results are shown in Table 9. It turned out that the skin external preparation of this invention is excellent in use feeling, and its stability is also high. It has also been found that it is preferable to include glycerin-modified methylpolysiloxane in the slurry.
<評価例2>
日焼け後1日の人5人に右腕に皮膚外用剤1を、左腕に比較例1を塗布してもらい、塗布時と塗布後の刺激感を答えてもらった。結果は5人とも皮膚外用剤1の方が刺激感を感じないと答えた。これはアルコール添加によるのびの改善によるものであると推察する。
<Evaluation Example 2>
Five people a day after sunburn applied the topical skin preparation 1 on the right arm and Comparative Example 1 on the left arm, and answered the feeling of irritation during and after application. As a result, all five responded that the external preparation for skin 1 did not feel irritation. This is presumed to be due to the improvement of the spread by the addition of alcohol.
本発明は、紫外線防護化粧料等の皮膚外用剤に応用できる。 The present invention can be applied to a skin external preparation such as an ultraviolet protective cosmetic.
Claims (7)
前記1)粉体と、3)グリセリン変性メチルポリシロキサンとを、油性担体に分散させ、スラリーとする工程、
前記スラリーと他の油相成分を混合して油相とする工程、及び
前記油相と2)低級アルコール3〜20質量%を含有する水相を混合して乳化させる工程、
を含む皮膚外用剤の製造方法。 1) a powder, 2) a lower alcohol, and 3) a method for producing an emulsifier-type skin external preparation containing glycerin-modified methylpolysiloxane,
A step of dispersing the 1) powder and 3) glycerin-modified methylpolysiloxane in an oily carrier to form a slurry;
A step of mixing the slurry and other oil phase components to form an oil phase, and a step of mixing and emulsifying the oil phase and 2) an aqueous phase containing 3 to 20% by mass of a lower alcohol,
A method for producing a topical skin preparation comprising:
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012228518A JP5653401B2 (en) | 2012-10-16 | 2012-10-16 | Method for producing powder-containing external preparation for skin containing emulsifier |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012228518A JP5653401B2 (en) | 2012-10-16 | 2012-10-16 | Method for producing powder-containing external preparation for skin containing emulsifier |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007257678A Division JP5184031B2 (en) | 2007-10-01 | 2007-10-01 | Emulsifier-type powder-containing external skin preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2013035872A JP2013035872A (en) | 2013-02-21 |
JP5653401B2 true JP5653401B2 (en) | 2015-01-14 |
Family
ID=47885789
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012228518A Active JP5653401B2 (en) | 2012-10-16 | 2012-10-16 | Method for producing powder-containing external preparation for skin containing emulsifier |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5653401B2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3292857A4 (en) * | 2015-05-07 | 2019-01-02 | Shin-Etsu Chemical Co., Ltd. | Cosmetic composition |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4798995B2 (en) * | 2004-04-28 | 2011-10-19 | 株式会社コーセー | Irregularity correcting cosmetic, skin irregularity correcting method, and irregularity correcting cosmetic set |
JP2007039362A (en) * | 2005-08-02 | 2007-02-15 | Pola Chem Ind Inc | Slurry for production and external preparation for skin, containing the same |
JP4684895B2 (en) * | 2006-01-07 | 2011-05-18 | 日本メナード化粧品株式会社 | Sunscreen cosmetics |
JP2007291094A (en) * | 2006-03-31 | 2007-11-08 | Kose Corp | Water-in-oil type sunscreen cosmetic |
JP5096030B2 (en) * | 2007-03-30 | 2012-12-12 | 株式会社コーセー | Oil-in-water sunscreen cosmetics |
-
2012
- 2012-10-16 JP JP2012228518A patent/JP5653401B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2013035872A (en) | 2013-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5184031B2 (en) | Emulsifier-type powder-containing external skin preparation | |
JP4943128B2 (en) | Powder-containing cosmetic | |
JP2008019230A5 (en) | ||
JP4874077B2 (en) | Surface-treated powder and cosmetics containing the surface-treated powder | |
JP5827079B2 (en) | Powder-containing skin external preparation | |
JP2015168635A (en) | Water-in-oil type emulsion cosmetic and method for manufacturing the same | |
JP2008143836A5 (en) | ||
JP2007039362A (en) | Slurry for production and external preparation for skin, containing the same | |
JP2007277191A (en) | Cosmetic of oil-in-water type emulsion dosage form | |
JP5340588B2 (en) | Cosmetics for correcting pores | |
JP5653401B2 (en) | Method for producing powder-containing external preparation for skin containing emulsifier | |
JP5016891B2 (en) | Powder cosmetics | |
JP2007039372A (en) | Cosmetic suitable for correction of pore | |
JP2008297239A (en) | Water-in-oil type external preparation for skin | |
JP5201658B2 (en) | Multi-layer treated powder-containing aqueous skin preparation | |
JP2008120756A (en) | Emulsified skin external preparation containing powder | |
JP2006342099A (en) | Cosmetic for lip part | |
JP2008120757A (en) | Emulsified skin external preparation containing powder treated with hydroxyapatite | |
JP2008120757A5 (en) | ||
JP6862100B2 (en) | Water emulsified cosmetics in oil | |
JP2007001867A5 (en) | ||
JP2008222651A (en) | External preparation for skin in emulsifier form | |
JP2009155243A (en) | Skin preparation for external use of powdery material-containing emulsified preparation form | |
JP2006321725A (en) | Emulsion-form skin preparation for external use | |
JP4741821B2 (en) | Skin external preparation suitable for sebum shine prevention |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20131001 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20140304 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140530 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20140606 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140805 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20141028 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20141118 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5653401 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |